US Regulator Delays Wall Street's AI Compute Futures Initiative
📊 CME — Piyasa Yorumu
■ neutral · 55%The news reports that CME's artificial intelligence compute futures initiative has been delayed by the US regulator, a mildly negative development that postpones the revenue potential of the new product in the near term. However, since CME's core business model does not depend on this initiative, the impact may remain limited. The technical picture is moderately positive: the price is above the SMA20 and SMA50, the RSI at 58.8 is far from overbought territory, and the MACD is above its signal line. Therefore, any selling pressure from the news may be offset by technical support. I expect a neutral to slightly volatile course over the 1-3 day horizon; for a clear direction, volume and the preservation of SMA20 support around 306 should be monitored.
📊 CBOE — Piyasa Yorumu
■ neutral · 55%The report states that CBOE's artificial intelligence compute futures initiative has been delayed by the US regulator, a mildly negative development that postpones the company's new product revenue potential in the near term. However, the stock already shows strong momentum: the last close was 361.16, above the SMA20 and SMA50, with a 24-hour change of +3.69% and an RSI14 of 67.6, close to the overbought threshold. MACD is above the signal line (3.43 vs 3.24) and trending positive, indicating that buying activity continues. The delay news may limit upside momentum in the near term and could serve as an excuse for profit-taking, but it is not enough to break the trend. Therefore, I view the 1-3 day outlook as neutral, slightly choppy, but with an uncertain direction.